Risk stratified follow up for head and neck cancer patients - An evidence based proposal.
Follow-up
Head neck cancer
Recurrence
Response
Survival
Toxicity
Journal
Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
18
02
2021
revised:
11
05
2021
accepted:
23
05
2021
pubmed:
1
6
2021
medline:
2
2
2022
entrez:
31
5
2021
Statut:
ppublish
Résumé
Head and neck squamous cell carcinoma (HNSCC) has a significant impact on patients' quality of life and treatment can be associated with severe morbidity. Following completion of treatment, patients are followed up in order to detect potentially salvageable recurrences and to manage long-term toxicities. In recent years, a growing interest has been given to risk stratified follow-up interventions to prevent and detect recurrences and manage treatment toxicities in other tumour sites as well as to transfer some of that care to community services. We review the literature for HNSCC and propose a risk stratified follow up protocol to address these issues and assist clinicians in decision making. A shift in patterns of care is suggested in order to provide a basis to improve care for HNSCC patients after complete response to primary treatment.
Identifiants
pubmed: 34058702
pii: S1368-8375(21)00188-3
doi: 10.1016/j.oraloncology.2021.105365
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105365Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.